Hutchison MediPharma
Pharmaceutical ManufacturingShanghai, China501-1000 Employees
Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering and developing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. It has a portfolio of cancer drug candidates currently in clinical studies around the world. It is a subsidiary of Chi-Med (Hutchison China MediTech, Nasdaq/AIM: HCM). HMP's strategic partnerships involve global, innovative companies such as AstraZeneca and Eli Lilly.